Hemostats Global Market Report 2025

A hemostat is a surgical tool employed in various surgical procedures to control or compress bleeding vessels, facilitating the treatment of wounds and aiding in visualizing deeper regions during surgeries.

There are several types of hemostats, including thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. Thrombin-based hemostats are used to control and reduce blood loss during surgical procedures, either in conjunction with or as an alternative to traditional surgical techniques. Thrombin is an enzyme that breaks down fibrinogen into fibrin, promoting blood clotting. Examples of active hemostats include topical (bovine) thrombin (Thrombin-JMI), topical (human) thrombin (Evithrom), and topical (recombinant) thrombin (Recothrom). They are available in various forms, such as active hemostats, passive hemostats, combination hemostats, and others. Formulations include matrix and gel hemostats, sheet and pad hemostats, sponge hemostats, and powder hemostats. These hemostats find applications in orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery, gynecological surgery, and other medical procedures.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The hemostats market research report is one of a series of new reports from The Business Research Company that provides hemostats market statistics, including hemostats industry global market size, regional shares, competitors with a hemostats market share, detailed hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the hemostats industry. This hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemostats market size has grown strongly in recent years. It will grow from $3.37 billion in 2024 to $3.56 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to surgical advancements, rising geriatric population, chronic diseases and coagulation disorders, expansion of cardiovascular surgeries, orthopedic applications.

The hemostats market size is expected to see strong growth in the next few years. It will grow to $4.66 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to emergency preparedness and pandemic response, global healthcare infrastructure development, growing demand for minimally invasive surgeries, expanding applications in various specialties, focus on biocompatibility. Major trends in the forecast period include product innovations, advancements in hemostatic technologies, focus on minimally invasive surgeries.

The forecast of 7.0% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for bipolar forceps with irrigation channels and titanium surgical clips, sourced from key regions such as Italy and South Korea, which could lead to reduced surgical hemostasis options and increased operating room supply expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

An increase in surgical procedures is expected to propel the growth of the hemostat market going forward. Surgical procedures refer to all forms of invasive treatments that are used on a person to investigate or treat a pathological condition. Hemostats are essential for surgical procedures as they are used to prevent blood loss while performing surgery. For instance, in September 2023, according to the International Society of Aesthetic Plastic Surgery, a Lebanon-based professional organization for board-certified plastic surgeons, there was an 11.2% overall increase in procedures performed by plastic surgeons in 2022, with more than 14.9 million surgical and 18.8 million non-surgical procedures performed worldwide. Additionally, both surgical and non-surgical procedures showed increases since the last survey (16.7% and 7.2% respectively). Therefore, an increase in surgical procedures is driving the growth of the hemostat market.

The hemostat market is poised for further growth, driven by government initiatives aimed at providing free surgeries. Free surgeries, performed without charging patients, alleviate the treatment burden on the economically disadvantaged. A survey conducted in tertiary care hospitals across India, as reported in a May 2022 article on PubMed, revealed a significant impact. Approximately 41.7% of respondents performed both laparoscopic and open procedures equally, demonstrating the diverse application of hemostats. The surge in surgical demand, especially with the trend toward hemostat usage, emphasizes the pivotal role of government initiatives in propelling the hemostat market's growth.

Technological advancement emerges as a key trend shaping the hemostat market, with major companies investing in new technologies and research and development efforts. Baxter, a prominent US-based healthcare company, exemplifies this trend through the launch of PERCLOT Absorbable Hemostatic Powder in March 2022. This passive, absorbable hemostatic powder is designed for patients with intact coagulation to address mild bleeding, providing surgeons with a versatile tool for bleeding control. The emphasis on technological innovation highlights the commitment to optimizing patient care and expanding the range of hemostatic solutions.

Major companies in the hemostat market are strategically engaging in partnerships and collaborations, particularly with start-ups and mid-sized companies, to enhance their product and service offerings. In May 2023, Olympus, a Japan-based manufacturer of optics and reprography products, expanded its partnership with Endoclot, a US-based medical device company. This collaboration aims to launch hemostatic agents, contributing to safe treatment in gastrointestinal procedures. By entering strategic partnerships, companies like Olympus seek to broaden their product portfolios and geographical reach, ultimately elevating the standard of care and improving patient outcomes in the hemostat market.

In December 2022, Integra LifeSciences, a US-based medical technology company, acquired Surgical Innovation Associates for $150 million. This acquisition allows Integra LifeSciences Holding Corporation to enhance its product portfolio, expand its market reach, and strengthen its position in the medical technology sector. Surgical Innovation Associates is a US-based company specializing in providing advanced surgical technologies and solutions.

Major companies operating in the hemostats market are B. Braun Melsungen AG, Baxter International Inc., Integra LifeSciences Corporation, Becton Dickinson and Company, Teleflex Incorporated, Medtronic PLC, Hemostasis LLC, Stryker Corporation, Advanced Medical Solutions Group PLC, Samyang Holdings Corporation, Gelita Medical GmbH, CryoLife Inc., CuraMedical B.V., Meril Life Sciences Pvt. Ltd., Beijing Datsing Bio-Tech Co. Ltd., Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd., Biotemed Inc., Biom'up SA, Shandong Foryou Medical Devices Co. Ltd., Z-Medica LLC, Anika Therapeutics Inc., Metalcraft Solutions Inc.

North America was the largest region in the hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemostat market consists of sales of cellulose based and thrombin-based hemostats. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemostats Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemostats market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Thrombin-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats; Combination Hemostats; Gelatin-Based Hemostats; Collagen-Based Hemostats
• 2) By Product: Active Hemostats; Passive Hemostats; Combination Hemostats; Other Products
• 3) By Formulation: Matrix And Gel Hemostats; Sheet And Pad Hemostats; Sponge Hemostats; Powder Hemostats
• 4) By Application: Orthopedic Surgery; General Surgery; Neurological Surgery; Cardiovascular Surgery; Reconstructive Surgery; Gynecological Surgery; Other Applications
• Subsegments:
• 1) By Thrombin-Based Hemostats: Topical Thrombin; Lyophilized Thrombin
• 2) By Oxidized Regenerated Cellulose-Based Hemostats: Pads; Granules
• 3) By Combination Hemostats: Thrombin And Gelatin Combinations; Thrombin And Collagen Combinations
• 4) By Gelatin-Based Hemostats: Gelfoam; Gelatin Sponge
• 5) By Collagen-Based Hemostats: Collagen Sheets; Collagen Powder
• Companies Mentioned: B. Braun Melsungen AG; Baxter International Inc.; Integra LifeSciences Corporation; Becton Dickinson and Company; Teleflex Incorporated; Medtronic PLC; Hemostasis LLC; Stryker Corporation; Advanced Medical Solutions Group PLC; Samyang Holdings Corporation; Gelita Medical GmbH; CryoLife Inc.; CuraMedical B.V.; Meril Life Sciences Pvt. Ltd.; Beijing Datsing Bio-Tech Co. Ltd.; Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd.; Biotemed Inc.; Biom'up SA; Shandong Foryou Medical Devices Co. Ltd.; Z-Medica LLC; Anika Therapeutics Inc.; Metalcraft Solutions Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.